LyondellBasell Industries N.V. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LyondellBasell Industries N.V. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.15B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $33.39B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $33.34B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $50.45B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $46.17B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $7.94B | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $6.78B | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $5.55B | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $7.49B | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $8.18B | Feb 25, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.15B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $33.39B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $33.34B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $50.45B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $46.17B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $27.00B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $33.91B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $38.13B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $33.71B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $28.45B | Feb 21, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $9.14B | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $8.52B | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $8.40B | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $8.43B | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $7.75B | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $7.37B | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $7.33B | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $6.74B | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $7.07B | Feb 17, 2017 |
| FY2016 | Sep 30, 2015 | $8.33B | Feb 17, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.23B | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $891.00M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $652.00M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $626.00M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $1.14B | Feb 25, 2021 |
| FY2020 | Sep 30, 2019 | $1.45B | Feb 25, 2021 |
| FY2020 | Jun 30, 2019 | $1.51B | Feb 25, 2021 |
| FY2020 | Mar 31, 2019 | $1.33B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.15B | Feb 20, 2020 |
| FY2019 | Sep 30, 2018 | $1.66B | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $3.40B | Feb 20, 2020 |
| FY2019 | Dec 31, 2018 | $4.69B | Feb 20, 2020 |
| FY2019 | Dec 31, 2017 | $4.88B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $3.84B | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $4.48B | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $4.17B | Feb 17, 2017 |
| FY2015 | Dec 31, 2013 | $3.86B | Feb 16, 2016 |
| FY2014 | Dec 31, 2012 | $2.85B | Feb 17, 2015 |
| FY2013 | Dec 31, 2011 | $2.15B | Feb 20, 2014 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($420.00M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.92B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.73B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $5.10B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $6.77B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $893.00M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $23.00M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $339.00M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $304.00M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $798.00M | Feb 25, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $135.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $130.00M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $124.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $124.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $113.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $111.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $115.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $106.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $99.00M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.64B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.54B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.31B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.26B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.14B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.20B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.13B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $859.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $833.00M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.82B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $4.94B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $6.12B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $7.70B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.40B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.96B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $5.47B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $5.21B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $5.61B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.84B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.53B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.89B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.96B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.95B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.69B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.11B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.55B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.24B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.00B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $35.75B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $37.00B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $36.37B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $36.74B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $35.40B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $30.44B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $28.28B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $26.21B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $23.44B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.08B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $12.46B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $12.93B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $12.62B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $11.86B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.97B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $8.04B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $10.26B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $8.95B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $6.05B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $708.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.56B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.65B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.83B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.88B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.95B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.89B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.81B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $570.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $528.00M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.81B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $9.33B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $9.69B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.20B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $8.56B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $4.44B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.44B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $6.76B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $15.75B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $12.28B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.44B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.38B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.39B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.15B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.47B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.76B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $858.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $332.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.52B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $875.00M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $5.77B | Feb 20, 2014 |
| FY2012 | Dec 31, 2012 | $4.30B | Feb 12, 2013 |
| FY2011 | Dec 31, 2011 | $3.98B | Feb 29, 2012 |
| FY2011 | Dec 31, 2010 | $6.04B | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 11 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 16 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 11 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 16 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 322.08M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 323.89M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 324.48M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 325.72M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 329.54M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 334.02M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 333.48M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 375.70M | Feb 20, 2020 |
| FY2017 | Dec 31, 2017 | 394.51M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | 404.05M | Feb 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.72B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.61B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $3.25B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.49B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.41B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.46B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.55B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.42B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.40B | Feb 21, 2019 |